Patients as Partners in Clinical Research

Memo

The 9th annual Patients as Partners is guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. Key Topic Areas Include:- Applying Patient Engagement Initiatives and Demonstrating Impact- Patient Input to Help R&D Obtain Better Outcomes from Clinical Research- FDA Guidance Updates and New Agency Efforts- Returning Data to Patients- Advancing Hybrid/Decentralized Clinical Trial Initiatives- Community Engagement & Building Trust to Ensure Diversity, Equity and Inclusion in Clinical Research- Operationalizing Patient Engagement From Research Through to Commercialization- New Tools for Patient Experience Mapping, Optimizing Digital Inclusion and Increasing Diversity and Inclusion in Clinical Trials- Collaborative Efforts for Reducing the Burden at the Site Level to Better Serve Patients PLUS... Interactive Sessions Including:- Hackathon on Patient-Centered Clinical Trial Solutions- Mapping Hybrid/DCT Opportunities in Medicines Development- Birds of a Feather Roundtable Discussions Why Patients as Partners is a Must Attend Annual Conference:- Learn from the 18+ case examples from Pharma R&D and Patient Organizations on HOW they are making significant progress involving patients in clinical research- 5 FDA agencies provide their updates and guidance on advancing patient involvement in medicines development- Meet directly with patients to gain their perspectives on clinical trial experiences, challenges and opportunities for improvement- 5+ Interactive collaborative problem solving sessions to advance patient involvement and drive greater efficiencies in clinical research- 6+ hours of in-person networking ranging from networking breaks, lunch, receptions, partnering opportunities, and more Tickets https://go.evvnt.com/976623-0?pid=5569Brochure https://go.evvnt.com/976623-3?pid=5569 Prices:Standard Rate USD 1595.00Academia, Non-Profit & Government Rate USD 797.50 Speakers: Adrelia Allen, PharmD, Merck Research Labs, Jimmy Bechtel, Society for Clinical Research Sites, Robyn Bent, Center for Drug Evaluation and Research (CDER), FDA, Kai Bode, Merck, Marc Boutin, Novartis, Sara Bristol Calvert, PharmD, Clinical Trials Transformation Initiative (CTTI), Susan Burriss, GSK, Xuemei Cai, MD, Pfizer, Katherine Capperella, Janssen Pharmaceuticals, Luther T Clark, MD, FACC, FACP, Merck, MarieElena Cordisco, NP-C, APRN, Nuvance Health, Ebony Dashiell-Aje, PhD, BioMarin Pharmaceutical Inc., Lukas Eichmann, Novo Nordisk, Cathy Florek, BMS, Andrea Furia-Helms, Director, Patient Affairs Staff, Office of Clinical Policy and Programs (OCPP) FDA, Jennifer Goldsack, MBA, Digital Medicine Society (DiMe), Scott Gray, Clincierge, Sarah Hamirani, Genentech, Stacy Hurt, MHA, MBA, Patient Advocate, Caregiver, Consultant, Karen Jackler, Center for Biologics Evaluation and Research, FDA, Lisa La Luna, WCG, Yasmeen Long, FasterCures, Susan Manoff, MD, MPH, Merck, Pooja Merchant, MD, Bayer Pharmaceuticals, Mary Stober Murray, MPH, National Minority Quality Forum (NMQF), Carrie Northcott, PhD, Pfizer, Elisabeth Oehrlein, PhD, National Health Council, Karen Peterson, Karen's Club, Jeanne Regnante, LUNGevity Foundation, Ash Rishi, COUCH Health, Traceann Rose, Children’s Tumor Foundation, Anindita Saha, Center for Devices and Radiological Health (CDRH), FDA, Roslyn Schneider, MD, Theravance Biopharma US, Suzanne Schrandt, ExPPect, Ebony Scott, Lupus Therapeutics, LLC, Jessica Scott, MD, JD, Takeda, Maura Snyder, Janssen, Cameron Sze, RN, Dana Farber Cancer Institute, Michelle Tarver, MD, PhD, Center for Devices and Radiological Health (CDRH), FDA, Sheila Thomas, PharmD, Sanofi, Cathy Trzaskawka (Traz), BMS, Hilary Wilson, PhD, Boehringer Ingelheim, John Yonchuk, GSK Date and Time: Starts: Thu, Apr 28, 2022 ( 7:45 AM) and Ends: Fri, Apr 29, 2022 ( 4:00 PM) Venue details: TBC, Philadelphia, United States